Notice Number: NOT-TW-19-001
Key Dates
Release Date: January 11, 2019
PAR-19-098
PAR-19-051
Issued by
National Institutes of Health (NIH)
Fogarty International Center (FIC)
National Cancer Institute (NCI)
National Human Genome Research Institute (NHGRI)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Office of Research on Women’s Health (ORWH)
Purpose
The purpose of this notice is to provide Letter of Intent guidance for PAR-19-098 Emerging Global Leader Award (K43; Independent Clinical Trial Not Allowed) and PAR-19-051 Emerging Global Leader Award (K43; Independent Clinical Trial Required)
Letter of Intent
The following Letter of Intent guidance should appear in the following section:
Section IV. Application and Submission Information
2. Content and Form of Application submission
Letter of Intent
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information of PAR 19-051 and PAR-19-098, prospective applicants are asked to submit a letter of intent that includes the following information:
- Descriptive title of proposed activity
- Name(s), address(es), and telephone number(s) of the PD(s)/PI(s)
- Names of other key personnel
- Participating institution(s)
- Number and title of this funding opportunity
The letter of intent should be emailed to:
Christine Jessup, Ph.D.
Telephone: 301-496-1653
Email: [email protected]
All other aspects of the FOAs remain unchanged.
Inquiries
Please direct all inquiries to:
Christine Jessup, Ph.D.
Telephone: 301-496-1653
Email: [email protected]
and Human Services (HHS)
